Table 2 Laboratory findings and imaging results in 159 patients categorized in cancer, and without cancer subgroups and 53 cancerous patients categorized into alive and dead
W/O cancer N (%)a | Cancer N (%) | p value | Cancer | p value | ||
|---|---|---|---|---|---|---|
Alive; N = 26 (%) | Dead; N = 27 (%) | |||||
Covid RT-PCR | ||||||
Positive | 44 (41.5) | 20 (37.7) | 0.887 | 8 (30.8) | 12 (44.4) | 0.137 |
Hemoglobin (g/dl) | ||||||
< 10 | 10 (9.4) | 24 (45.3) | 0.000 | 10 (38.5) | 14 (51.9) | 0.404 |
> 10 | 86 (81.1) | 28 (52.8) | 16 (61.5) | 12 (44.4) | ||
Missing | 10 (9.4) | 1 (1.9) | – | 1 (3.7) | ||
Platelet (/microliter) | ||||||
< 150,000 | 24 (22.6) | 29 (54.7) | 0.000 | 10 (38.5) | 19 (70.4) | 0.025 |
> 150,000 | 71 (67) | 23 (43.4) | 16 (61.5) | 7 (25.9) | ||
Missing | 10 (9.4) | 1 (1.9) | – | 1 (3.7) | ||
WBC (/microliter) | ||||||
< 4000 | 11 (10.4) | 15 (28.3) | 0.000 | 8 (30.8) | 7 (25.9) | 0.779 |
4000–12,000 | 70 (66) | 18 (34) | 10 (38.4) | 8 (29.6) | ||
> 12,000 | 15 (14.2) | 19 (35.8) | 8 (30.8) | 11 (40.7) | ||
Missing | 10 (9.4) | 1 (1.9) | – | 1 (3.7) | ||
Lymphocyte (/microliter) | ||||||
< 1000 | 34 (32.1) | 15 (28.3) | 0.082 | 12 (46.2) | 5 (18.5) | 0.028 |
1000–4000 | 35 (33) | 17 (32.1) | 10 (38.4) | 5 (18.5) | ||
> 4000 | 1 (0.9) | 4 (7.5) | 0 | 4 (14.8) | ||
Missing | 36 (34) | 17 (32.1) | 4 (15.4) | 13 (48.2) | ||
Neutrophil (/microliter) | ||||||
< 1500 | 1 (0.9) | 7 (13.2) | 0.000 | 5 (19.2) | 2 (7.4) | 0.908 |
1500–7700 | 52 (49.1) | 15 (28.3) | 9 (34.6) | 6 (22.2) | ||
> 7700 | 17 (16) | 14 (26.4) | 8 (30.8) | 6 (22.2) | ||
Missing | 36 (34) | 17 (32.1) | 4 (15.4) | 13 (48.2) | ||
pH | ||||||
< 7.25 | 4 (3.8) | 5 (9.4) | 1 (3.8) | 4 (14.8) | ||
7.25–7.35 | 6 (5.7) | 6 (11.3) | 3 (11.5) | 3 (11.1) | ||
7.35–7.45 | 65 (61.2) | 35 (66.1) | 0.372 | 20 (76.9) | 15 (55.6) | 0.462 |
> 7.45 | 18 (17) | 6 (11.3) | 2 (7.7) | 4 (14.8) | ||
Missing | 13 (12.3) | 1 (1.9) | – | 1 (3.7) | ||
PCO2 (mmHg) | ||||||
< 35 | 26 (24.5) | 16 (30.2) | 0.769 | 5 (19.2) | 11 (40.7) | 0.008 |
35–45 | 41 (38.7) | 19 (35.9) | 15 (57.7) | 4 (14.8) | ||
> 45 | 24 (22.6) | 14 (26.4) | 5 (19.2) | 9 (33.3) | ||
Missing | 15 (14.2) | 4 (7.5) | 1 (3.8) | 3 (11.1) | ||
HCO3 (mEq/L) | ||||||
< 22 | 23 (21.7) | 21 (39.6) | 0.100 | 6 (23.1) | 15 (55.6) | 0.018 |
22–26 | 30 (28.3) | 13 (24.6) | 10 (38.4) | 3 (11.1) | ||
> 26 | 38 (35.8) | 15 (28.3) | 9 (34.6) | 6 (22.2) | ||
Missing | 15 (14.2) | 4 (7.5) | 1 (3.8) | 3 (11.1) | ||
Na (mEq/L) | ||||||
< 135 | 16 (15.1) | 9 (17) | 0.739 | 5 (19.2) | 4 (14.8) | 0.790 |
135–145 | 76 (71.7) | 40 (75.5) | 19 (73.1) | 21 (77.8) | ||
> 145 | 3 (2.8) | 3 (5.6) | 2 (7.7) | 1 (3.7) | ||
Missing | 11 (10.4) | 1 (1.9) | – | 1 (3.7) | ||
K (mEq/L) | ||||||
< 3.5 | 5 (4.7) | 3 (5.6) | 0.985 | 1 (3.8) | 2 (7.4) | 0.501 |
3.5–5 | 76 (71.7) | 40 (75.5) | 22 (84.6) | 18 (66.7) | ||
> 5 | 15 (14.2) | 8 (15.1) | 3 (11.5) | 5 (18.5) | ||
Missing | 10 (9.4) | 2 (3.8) | – | 2 (7.4) | ||
AST (IU/L) | ||||||
< 40 | 38 (35.8) | 14 (26.4) | 8 (30.8) | 6 (22.2) | ||
> 40 | 34 (32.1) | 31 (58.5) | 0.022 | 16 (61.5) | 15 (55.6) | 0.759 |
Missing | 34 (32.1) | 8 (15.1) | 2 (7.7) | 6 (22.2) | ||
ALT (IU/L) | ||||||
< 40 | 53 (50) | 28 (52.8) | 0.181 | 15 (57.7) | 13 (48.2) | 0.990 |
> 40 | 20 (18.9) | 18 (34) | 9 (34.6) | 9 (33.3) | ||
Missing | 33 (31.1) | 7 (13.2) | 2 (7.7) | 5 (18.5) | ||
ALK-p (IU/L) | ||||||
< 200 | 46 (43.4) | 14 (26.4) | 7 (26.9) | 7 (25.9) | ||
> 200 | 24 (22.6) | 31 (58.5) | 0.000 | 16 (61.5) | 15 (55.6) | 0.990 |
Missing | 36 (34) | 8 (15.1) | 3 (11.5) | 5 (18.5) | ||
PTT (seconds) | ||||||
< 45 | 70 (66) | 37 (69.8) | 19 (73.1) | 18 (66.7) | ||
> 45 | 2 (1.9) | 3 (5.6) | 0.246 | 3 (11.5) | 0 | 0.238 |
Missing | 34 (32.1) | 13 (24.6) | 4 (15.4) | 9 (33.3) | ||
INR | ||||||
< 1.5 | 60 (56.6) | 26 (49.1) | 13 (50) | 13 (48.2) | ||
> 1.5 | 14 (13.2) | 19 (35.8) | 0.006 | 10 (38.4) | 9 (33.3) | 0.990 |
Missing | 32 (30.2) | 8 (15.1) | 3 (11.5) | 5 (18.5) | ||
Total Bilirubin (mg/dl) | ||||||
< 1.5 | 47 (44.3) | 20 (37.7) | 12 (46.1) | 8 (29.6) | ||
> 1.5 | 7 (6.6) | 16 (30.2) | 0.001 | 6 (23.1) | 10 (37) | 0.315 |
Missing | 52 (49.1) | 17 (32.1) | 8 (30.8) | 9 (33.3) | ||
Creatinine (mg/dl) | ||||||
< 1.2 | 69 (65.1) | 35 (66) | 19 (73.1) | 16 (59.3) | ||
> 1.2 | 28 (26.4) | 17 (32.1) | 0.628 | 7 (26.9) | 10 (37) | 0.375 |
Missing | 9 (8.5) | 1 (1.9) | – | 1 (3.7) | ||
CRP¥ (mg/L) | 68.7 (27; 82) | 79 (43; 98) | 0.033 | 70 (19.5;101.5) | 79 (76.5;95) | 0.282 |